Podcasts about FACS

In this episode, we sit down with Dr. Sharon Webb, founder and lead physician of Southern Regenerative and Neurological Wellness. Dr. Webb is a board-certified neurosurgeon with more than two decades of experience in neurological surgery, endovascular neurosurgery, and regenerative medicine. She earned her medical degree from the University of South Carolina School of Medicine and holds distinguished fellowships including FAANS, FACS, and FAHA.During our conversation, Dr. Webb shares her journey from treating complex brain and spine disorders in hospital systems to pioneering a more integrative approach that combines neurosurgery, regenerative medicine, and neurological wellness. We discuss brain health, recovery from neurological injuries, chronic pain, innovative regenerative therapies, and what the future of personalized medicine could look like for patients seeking better outcomes and improved quality of life.Whether you're interested in neuroscience, health optimization, regenerative medicine, or the latest approaches to neurological recovery, this episode offers valuable insights from one of the field's leading experts.Thank you so much for listening! If you would like to see more from Southern Regenerative & Neurological Wellness, you can find them here:Website: https://www.southernrnw.com/This episode is sponsored by Columbia Family Chiropractic: https://www.cfcforhealth.comhttps://www.instagram.com/columbiafamilychiropracticThis episode is sponsored by Gallup Design Build: ⁠https://www.gallupdesignbuild.com⁠⁠https://www.instagram.com/gallupdesignbuild⁠If you would like to follow us, we are on everything at Here For The Health Of It Podcast:https://www.instagram.com/columbiashottestpodcast/https://podcasters.spotify.com/pod/show/hereforthehealthofit

With a growing reliance on GLP-1 treatments for obesity, researchers at Vanderbilt University in Nashville, Tennessee, compared body composition changes between patients who used GLP-1s versus patients who underwent bariatric surgery for obesity treatment. In this episode, host Rick Greene, MD, FACS, talks with Jason M. Samuels, MD, FACS, one of the authors of Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists about the findings, which showed that while both treatments reduced fat mass, surgery helped preserve fat-free mass such as muscle and organ tissues. Talk about the podcast on social media using the hashtag #SurgicalReadings  

In this episode, we sit down with Dr. Sharon Webb, founder and lead physician of Southern Regenerative and Neurological Wellness. Dr. Webb is a board-certified neurosurgeon with more than two decades of experience in neurological surgery, endovascular neurosurgery, and regenerative medicine. She earned her medical degree from the University of South Carolina School of Medicine and holds distinguished fellowships including FAANS, FACS, and FAHA.During our conversation, Dr. Webb shares her journey from treating complex brain and spine disorders in hospital systems to pioneering a more integrative approach that combines neurosurgery, regenerative medicine, and neurological wellness. We discuss brain health, recovery from neurological injuries, chronic pain, innovative regenerative therapies, and what the future of personalized medicine could look like for patients seeking better outcomes and improved quality of life.Whether you're interested in neuroscience, health optimization, regenerative medicine, or the latest approaches to neurological recovery, this episode offers valuable insights from one of the field's leading experts.Thank you so much for listening! If you would like to see more from Southern Regenerative & Neurological Wellness, you can find them here:Website: https://www.southernrnw.com/This episode is sponsored by Columbia Family Chiropractic: https://www.cfcforhealth.comhttps://www.instagram.com/columbiafamilychiropracticThis episode is sponsored by Gallup Design Build: ⁠https://www.gallupdesignbuild.com⁠⁠https://www.instagram.com/gallupdesignbuild⁠If you would like to follow us, we are on everything at Here For The Health Of It Podcast:https://www.instagram.com/columbiashottestpodcast/https://podcasters.spotify.com/pod/show/hereforthehealthofit

GLP-1 medications like Ozempic and Wegovy are changing bodies fast. But what happens to your skin, face and overall appearance after dramatic weight loss? In this episode, Lauren sits down with New York Plastic & Reconstructive Surgeon Dr. David Kashan to talk about the growing rise in “Ozempic face,” loose skin, body contouring, facelifts, skin removal surgery and the very real aesthetic side effects many people aren't talking about. Dr. Kashan, who trained at the renowned Cleveland Clinic, shares what he's seeing firsthand in his practice during the GLP-1 boom. Together, they discuss who is most affected by rapid weight loss, the most common procedures patients are requesting now, how long patients should stop GLP-1 medications before surgery, and whether non-surgical treatments can help improve skin laxity, facial volume loss and overall skin quality before considering surgery. If you're a woman in midlife navigating weight loss, aging, confidence, skin changes or considering GLP-1 medications yourself, this conversation is packed with honest insight, practical advice, and expert perspective you'll definitely want to hear. Show Notes David L. Kashan MD, FACS, Plastic & Reconstructive Surgery (516) 515-9267 Website: davidkashanmd.com Instagram: @davidkashanmd  

Sustaining critical care delivery in today's healthcare environment requires more than resilience—it also calls for collective solutions to systemic challenges. In this episode of the Society of Critical Care Medicine (SCCM) Podcast, Past President Jose L. Pascual, MD, PhD, FRCS(C), FACS, FCCM, elaborates on the session presented during the 2026 Critical Care Congress, Critical Care Under Pressure: Sustaining the Workforce and Infrastructure Amid Rising Demands. Joined by host Marilyn Bulloch, PharmD, BCPS, FCCM, Dr. Pascual examines the complex forces reshaping critical care, from shrinking ICU capacity and hospital closures to persistent workforce shortages and shifting training pipelines. He highlights concerning trends such as reduced entry into certain critical care pathways, particularly anesthesiology. At the same time, he points to encouraging growth in other pathways, with increasing participation from clinicians in emergency medicine, neurology, and surgery. The conversation underscores disparities in access to care, particularly for rural and community hospitals. Dr. Pascual explores the tension between the regionalization of specialized care and the need to maintain equitable access across health systems, emphasizing the importance of thoughtful resource distribution and collaboration across institutions. Beyond workforce numbers, the evolution of leadership in critical care is also impactful, including the migration of experienced clinicians into administrative roles and the potential need for cyclical leadership models that maintain clinical engagement. Meeting these challenges requires innovation and cooperation. Dr. Pascual highlights advancements in education, particularly the expansion of simulation-based training, as critical tools for maintaining competency and improving team performance. Resources referenced in this episode:  2026 Congress Digital

George O. Waring IV, MD, FACS, speaks with Dagny C. Zhu, MD, about refractive lens exchange and her same-day bilateral refractive lens exchange workflow in an office-based surgery setting. Dr. Zhu discusses how refractive lens exchange fits into her cash-pay refractive practice, how her team screens and evaluates candidates, and the steps involved when patients proceed from consultation to surgery on the same day. She also shares her approach to diagnostic testing, patient counseling, premium IOL selection, oral sedation, femtosecond laser sequencing, refractive accuracy, and IOL calculations in eyes with a history of corneal refractive surgery.

In this episode, Lillian Erdahl, MD, FACS, is joined by Pringl Miller, MD, FACS, from Physican Just Equity, and Christine Heisler, MD, FACS, from the Mayo Clinic Health System. They discuss Drs Miller and Heisler's recent article, “Whether and How Surgeons Took Action Against Workplace Microaggression: Survey of American College of Surgeons Members,” in which the authors found that the most frequent perpetrator roles were surgeon colleagues and supervisors. A total of 57.4% of surgeons took action, with informal reporting to a colleague and/or directly confronting the perpetrator being most common actions taken. Surgeons who took action were less likely to choose a career in surgery again.   Disclosure Information: Drs Erdahl, Miller, and Heisler have nothing to disclose.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Heisler, Christine A MD, MS, FACS; Godecker, Amy L PhD, MS; Verran, Deborah MbChB, MHSM; Sinha, Michael S MD, JD, MPH; Byam, Jerome MD; Miller, Pringl MD, FACS. Whether and How Surgeons Took Action Against Workplace Microaggression: Survey of the American College of Surgeons Members. Journal of the American College of Surgeons 242(2):p 390-400, February 2026. | DOI: 10.1097/XCS.0000000000001648   Related work: Primary Study: Heisler CA, Godecker AL, Verran D, Sinha MS, Byam J, Miller P. Workplace microaggressions: results of a survey of the American College of Surgeons members. Am J Obstet Gynecol. 2024 Aug;231(2):265.e1-265.e8.   Secondary Study: Heisler CA, Godecker AL, Verran D, Sinha MS, Byam J, Miller P. Impact of Workplace Microaggressions on Surgeon Career Status and Trajectory: A Cross-Sectional Survey Study.  Accepted to the Annals of Surgery Open on April 30, 2026.     The secondary study was also presented at ACS Clinical Congress 2024: Heisler CA, Godecker A, Verran D, Sinha MS, Byam J, Miller P. Workplace Microaggressions and the Impact on a Surgeon's Career Trajectory: Results of a Survey of the American College of Surgeons Members. J Am Coll Surg. October 2024;239(5):S138-139.   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord

Event ObjectivesImplement at least one subtractive change in their practices.Understand the scope of healthcare delivery's environmental impact.Perform procedures with less materials waste and use.Claim CME Credit Here!

This is an episode unlike any we have shared before. The meaning of mentorship is spoken about on another level with Dr. Myron Tucker and Dr. Bryan Bell. Although they are linked in the traditional mentor/mentee way they also have bonded on the influence Dr. Bell's father has had on both of them. We encourage you to give this episode a listen, especially to the end where Dr. Bell shares a touching poem written about his first mentor, his father.

Send us Fan MailBladder cancer treatment is entering a new era. From gene therapy and bladder preservation to AI-assisted diagnostics and the challenge of detecting “hidden” CIS, Dr. Ravi Chauhan, MD, FACS breaks down the technologies and clinical decisions reshaping urology in 2026.Dr. Ravi Chauhan, MD, FACS ( https://conradpearson.com/our-specialists/ravi-d-chauhan-m-d-facs/ ) is a board-certified urologist, fellowship-trained uro-oncology specialist, and one of the leading voices in advanced kidney and bladder cancer care in the Mid-South.Born and raised in Memphis, Tennessee, Dr. Chauhan graduated Cum Laude from Rhodes College with a degree in molecular biology before earning his M.D. and completing both his general surgery internship and urologic surgery residency at The University of Tennessee Health Science Center. He joined the Conrad Pearson Clinic in 2005 and has since become a recognized leader in the treatment of advanced bladder and kidney cancers, with numerous publications and presentations to his name.Dr. Chauhan's path into medicine was deeply personal. Inspired by watching his father practice medicine and witnessing the profound impact physicians can have on patients and families, he developed a philosophy centered on treating every patient with the same compassion, respect, and attention he would want for his own family.In addition to his expertise in surgical urology and uro-oncology, Dr. Chauhan has become increasingly focused on one of the biggest challenges in modern bladder cancer management: identifying and treating high-risk non–muscle invasive bladder cancer - or NMIBC, particularly  carcinoma in situ - or CIS , which can often be difficult to detect in routine clinical practice.Today, we'll discuss the evolving diagnostic landscape for CIS, why missed or under-recognized disease can significantly impact treatment decisions, and the growing importance of collaboration between urologists and pathologists. We'll also explore how community urologists are navigating these rapidly evolving standards of care, the future of precision bladder cancer management, and what it means for patients facing this disease.We'll also discuss bladder-sparing approaches, including Adstiladrin® (nadofaragene firadenovec-vncg), an intravesical gene therapy for adults with high-risk Bacillus Calmette-Guerin (BCG)-unresponsive NMIBC with CIS, with or without papillary ( https://www.adstiladrin.com/ ).ADSTILADRIN should not be used in patients with hypersensitivity to interferon alfa or its components, and individuals who are immunosuppressed or immune-deficient should not handle or receive the therapy. Delaying cystectomy in patients with BCG-unresponsive CIS could lead to development of muscle invasive or metastatic bladder cancer, which can be lethal. If patients with CIS do not have a complete response to treatment after 3 months or if CIS recurs, consider cystectomy.The most common adverse reactions include urinary discharge, fatigue, bladder spasm, urgency to urinate, and blood in urine. Patients should consult their healthcare provider regarding all medications and report any side effects. Please see full Prescribing Information  ( https://d2hu1op93domjx.cloudfront.net/wp-content/uploads/sites/12/2026/03/24101239/ADSTILADRIN-USPI-Mar.2026-CLEAN.pdf ) for additional details.#BladderCancer #Urology #CancerResearch #BladderCancerAwareness #NMIBC #CarcinomaInSitu #CIS #UroOncology #GeneTherapy #CancerTreatment #PrecisionMedicine #BCG #BladderPreservation #MedicalInnovation #Oncology #CancerCare #Immunotherapy #HealthcareInnovation #UrologistSupport the show

Please visit answersincme.com/860/101385133-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Peter A. Fasching, MD; Michael Gnant, MD, FACS; and Cristina Saura Manich, MD, PhD. In this activity, experts in breast cancer discuss new evidence in neoadjuvant and adjuvant care of early disease. Upon completion of this activity, participants should be better able to: Describe multidisciplinary viewpoints on the role that HER2-directed ADCs may play in the (neo)adjuvant setting for HER2-positive early-stage breast cancer; Evaluate evidence for the (neo)adjuvant use of HER2-directed ADCs in the multidisciplinary management of HER2-positive early-stage breast cancer; and Formulate evidence-based multidisciplinary strategies to optimally incorporate (neo)adjuvant HER2-directed ADCs into the treatment paradigm for HER2-positive early-stage breast cancer.

In this episode, Stephen B. Williams, MD, MBA, MS, FACS, FACHE, Associate Chief Medical Officer, UTMB Clear Lake, Medical Director for High Value Care, UTMB Health System, Chief, Division of Urology, Professor (Tenured), Urology and Radiology, The Robert Earl Cone Professorship, Director of Urologic Oncology, The University of Texas Medical Branch,discusses physician leadership, operational transformation, and the growing impact of artificial intelligence in healthcare.

We're talking about Breast Implant Illness — BII. An estimated 400,000 women believe their implants are making them sick. Tens of thousands of adverse reports have been filed with the FDA. And with roughly 300,000 implant procedures performed every year in the US, this is a public health conversation we can no longer ignore. Women are reporting fatigue, brain fog, joint pain, hair loss, and autoimmune-like symptoms — often dismissed by doctors for years. The research is ongoing, but the FDA has added new warnings, and the conversation around patient safety and informed consent is finally gaining real traction Our guest, Sean Doherty, MD, FACS, is a board-certified plastic surgeon in Boston. Dr. Doherty is seeing an increasing number of patients seeking guidance on BII, including those considering implant removal or replacement. KEY TAKEAWAYS 1.    How breast implant illness (BII) is defined, and what has contributed to the growing awareness around it in recent years The most common symptoms in patients who are concerned about BII When a patient is concerned about possible breast implant illness, what the evaluation process looks like—from the first conversation through deciding next steps The risk factors or patient profiles that may make someone more susceptible to complications or symptoms associated with breast implants For patients who believe they may be experiencing BII, the options that are available to them How the field of plastic surgery has evolved in recent years to better prioritize patient safety, informed consent, and long-term outcomes when it comes to breast implants Is there such a thing as a safer implant or one designed for autoimmune patients? è You can learn about his services at: https://www.seandohertymd.com/   è You can find the links in the show notes at https://ronandlisa.com/podcast/. è Be sure to leave a review or rating – five stars are always appreciated. And, if you're not already subscribed…consider this your whisper!  

In this episode, R. Lawrence Moss, MD, FACS, FAAP, President and Chief Executive Officer, Nemours Children's Health, discusses why investing in childhood health can transform long-term outcomes for society, the role of healthcare systems in addressing social determinants of health, and Nemours Children's innovative work in kindergarten readiness and pediatric global budgeting.

In this episode live from Hawaiian Eye 2026, Cathleen McCabe, MD speaks with Marguerite McDonald, MD, FACS about her fascinating career that has spanned many decades. From shocking stories about ophthalmic research to being the first woman to pioneer a number of leadership roles in the field, Dr. McDonald shares her journey.  We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN. Mend the Gap would also like to give you the chance to nominate yourself or a colleague for a travel grant! To enter, simply email us at podcast@healio.com! ·        Welcome to this episode 1:23 ·        Marguerite McDonald, MD, FACS 1:35 ·        Tell us about your career, how did you start? 4:30 ·        How did you become the first person in the world to perform corneal refractive surgery? 9:27 ·        Radial keratotomy and a lawsuit 16:07 ·        Refractive surgery research 20:10 ·        Facing criticism 29:13 ·        Any motivating words for our audience? 35:12 ·        Thank you! 37:34 Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, Florida. Marguerite McDonald, MD, FACS, is a clinical professor of ophthalmology at NYU Langone Health and in private practice with OCLI in Long Island, NY.

In this episode, R. Lawrence Moss, MD, FACS, FAAP, President and Chief Executive Officer, Nemours Children's Health, discusses why investing in childhood health can transform long-term outcomes for society, the role of healthcare systems in addressing social determinants of health, and Nemours Children's innovative work in kindergarten readiness and pediatric global budgeting.

In this episode of The House of Surgery, Drs. Katrin Arnolds and Ana Pena discuss the realities of operating while pregnant. Drawing from their own experiences as surgeons and mothers, they share practical tips for staying safe and comfortable in the OR, managing prenatal appointments, navigating workplace expectations, and reducing exposure to radiation, anesthesia gases, surgical smoke, chemotherapy agents, and other potential hazards. This conversation offers valuable insight for pregnant surgeons, trainees, and anyone working alongside pregnant members of the surgical team. Talk about the podcast on social media using the hashtag #HouseofSurgery Katrin Arnolds, MD, is a board-certified minimally invasive gynecologic surgeon at the Cleveland Clinic in Weston, Florida Ana Pena, MD, FACS, is a board-certified general surgeon at the Cleveland Clinic in Weston, Florida     Copyright © 2026 by the American College of Surgeons (ACS). All rights reserved.   The contents of this podcast may be cited in academic publications but otherwise may not be reproduced, disseminated, or transmitted in any form by any means without the express written permission of ACS. These materials may not be resold nor used to create revenue-generating content by any entity other than the ACS without the express written permission of the ACS. The contents of these materials are strictly prohibited from being uploaded, shared, or incorporated in any third-party applications, platforms, software, or websites without prior written authorization from the ACS. This restriction explicitly includes, but is not limited to, the integration of ACS content into tools leveraging artificial intelligence (AI), machine learning, large language models, or generative AI technologies and infrastructures.

You've watched him pull away and wondered if something is actually wrong with his body — and you were right to wonder. Dr. Arthur Burnett, Johns Hopkins urologist, breaks down exactly what testosterone does (and doesn't) do for men's drive, erections, and mood — and why a basic blood test isn't the whole picture. If your husband has quietly gone cold and neither of you knows why, take the free "Why Is My Drive Low?" quiz at mylibidodoc.com/libido-quiz — it takes three minutes and points you toward real answers.

What are the experts saying about thyroid cancer treatment in 2025?  Maybe it's time to discuss deescalation of aggressive surgical care for lower risk thyroid cancers.  We can accept that less surgery may be appropriate in select cases, including more thyroid lobectomies versus total thyroidectomies, consider less invasive approaches such as percutaneous ablation techniques, and utilize more observation with active surveillance.  Early assessment of treatment may allow appropriate reduction in use of radioactive iodine ablation and more relaxed routine monitoring can reduce surveillance burden to patients and providers. Hosts:  - Amanda Doubleday, DO, MBA, Assistant Professor, Waukesha Surgical Specialists, ProHealth Care.  Affiliated with University of Wisconsin School of Medicine and Public Health, Department of Surgery.  - Simon Holoubek, DO, MPH, Assistant Professor, University of Wisconsin School of Medicine and Public Health, Department of Surgery.  - Alexander Chiu, MD, Assistant Professor, University of Wisconsin School of Medicine and Public Health, Department of Surgery.  - Rebecca S Sippel, MD, FACS, Professor and Chair of Division of Endocrine Surgery, Vice Chair of Academic Affairs and Professional Development, University of Wisconsin School of Medicine and Public Health, Department of Surgery.  Learning Objectives:- Risk stratification system now includes 4 categories: low, low-intermediate, high-intermediate, and high-TSH suppression targets are simplified:  below the normal range if there is structural or biochemical disease and in the normal range if disease free. - Thyroid lobectomy is recommended for tumors < 2cm cT1N0 tumors and can be considered for tumors 2-4 cm. - Micro-Papillary Thyroid Carcinoma (

Catch up if you can! 

In this episode, host Rick Greene, MD, FACS, talks with Ronald J. Weigel, MD, PhD, MBA, FACS, Medical Director of ACS Cancer Programs, about a new report from the ACS National Cancer Database (NCDB) that notes key trends in cancer treatment, as well as in-depth reports on outcomes for prostate cancer, esophageal cancer, and melanoma. Dr. Weigel also describes the history of the NCDB and future plans that will lead to more rapid and robust insights on cancer occurrence and treatment. Talk about the podcast on social media using the hashtag #SurgicalReadings

In this episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026 with guests Elizabeth Yeu, MD, and Allen C. Ho, MD. They discuss cataract and retina surgery, managing work-life balance and more. ·        Welcome to Eyeluminaries. 00:01 ·        Elizabeth Yeu, MD, 00:11 ·        How do you see Implantable Collamer Lens (ICL, STAAR Surgical) surgery expanding? 01:23 ·        How long have you been with Tarsus Pharmaceuticals? 05:00 ·        How do you have work-life balance? 08:21 ·        Allen C. Ho, MD 11:38 ·        What got you into retina? 12:55 ·        How has the evolution of retina surgery changed your practice? 14:55 ·        Tell us about your role at Eyecelerator. 17:00 ·        How do you manage your work-life balance? 18:39 ·        Thank you! 20:19 Elizabeth Yeu, MD, is an ophthalmologist and cornea and cataract surgeon. She is the chief medical officer of Tarsus Pharmaceuticals as well as past president of the American Society of Cataract and Refractive Surgery. Allen C. Ho, MD, is a retina surgeon at Wills Eye Hospital, past president of the Retina Society and Eyecelerator retina program chair. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John A. Hovanesian, MD, FACS @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.  

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Robert A Meguid, MD, MPH, FACS, a thoracic and cardiac surgeon, as well as a professor of cardiothoracic surgery, at the University of Colorado in Aurora.Drs Camidge and Meguid discussed Dr Meguid's journey into medicine, which was heavily influenced by his parents, both of whom were academic physicians. A first-generation American, Dr Meguid grew up watching his father operate and working in his father's research lab, experiences that ignited a lifelong interest in the scientific method and patient care. Dr Meguid pursued a combined 8-year medical program before matching into a residency in general surgery. During his residency, he spent 3 years in research, earning a master's degree in public health and shifting his focus toward surgical outcomes and risk analysis. After completing a cardiothoracic fellowship, he joined the University of Colorado, where he helped expand the thoracic surgery program and pioneered robotic-assisted techniques.A shift in Dr Meguid's perspective occurred when he suffered a life-threatening medical event during a family vacation in Australia. He contracted fulminant septic shock resulting from human metapneumovirus and group A strep, leading to respiratory and renal failure. After being intubated for several weeks and losing significant muscle mass, he was life-flighted back to his own ICU in Denver to begin recovery. This experience as a patient, during which he had to relearn how to stand and move, deepened his empathy and reinforced his commitment to patient-centered care.Currently, Dr Meguid is a leader in his field, focusing on thoracic oncology and complex chest wall reconstructions, such as that of the adult pectus excavatum. He remains dedicated to academic research on surgical risk assessment, ensuring that patients are empowered to make informed decisions about their care.

This mini-series on Behind the Knife delves into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program and Cancer Surgery Standards Program. This episode highlights sentinel lymph node biopsy for breast cancer.Hosts:- Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a Surgical Oncology fellow at MD Anderson Cancer Center.- Lauren Postlewait, MD, FACS, is an Associate Professor of Surgery at Emory University School of Medicine and is the Medical Director of the Breast Center at Grady Memorial Hospital in Atlanta, GA.- Chantal Reyna, MD, FACS (@kprgrl3) is a Breast surgical oncologist at Loyola University Medical Center in Chicago, IL and serves as the oncology clinical lead for the breast service line.Guest:- Susan E. Pories, MD, FACS (@SusanPoriesMD) is a professor of surgery, vice chair for quality and safety, and director of the Rutger's Breast Center at the University hospital. Learning Objectives: -       Understand the definition and identification of axillary sentinel lymph node. -       Understand the technique for injecting tracer or dye to perform sentinel lymph node biopsy. -       Understand the importance of preincision drainage evaluation and transcutaneous localization.-       Understand techniques to minimize seroma formation.Links to Papers Referenced in this EpisodeOperative Standards for Cancer Surgery, Volume 1: Breast, Lung, Pancreas, Colonhttps://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/Kindle edition:https://www.amazon.com/Operative-Standards-Cancer-Surgery-Section-ebook/dp/B07MWSNFSBSentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol. 2010 Oct;11(10):927-33.https://pubmed.ncbi.nlm.nih.gov/20863759/Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection J Clin Oncol. 2016 Apr 1;34(10):1072-8.https://pubmed.ncbi.nlm.nih.gov/26811528/The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis World J Surg. 2012 Sep;36(9):2239-51. https://pubmed.ncbi.nlm.nih.gov/22569745/Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer Am J Surg. 2005 Oct;190(4):557-62.https://pubmed.ncbi.nlm.nih.gov/16164919/Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial JAMA Oncol. 2023 Nov 1;9(11):1557-1564.https://pubmed.ncbi.nlm.nih.gov/37733364/Choosing Wisely GuidelinesSociety of Surgical Oncology. Released 2016 July 12; last updated 2020 November 13. Choosing Wisely: Five Things Physicians and Patients Should Question.https://surgonc.org/wp-content/uploads/2020/11/SSO-5things-List_2020-Updates-11-2020.pdfPlease visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewOral Board Simulator: https://app.behindtheknife.org/oral-board-simulatorTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PRZ865. CME/MOC/CC/AAPA/IPCE credit will be available until April 20, 2027.Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PRZ865. CME/MOC/CC/AAPA/IPCE credit will be available until April 20, 2027.Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PRZ865. CME/MOC/CC/AAPA/IPCE credit will be available until April 20, 2027.Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PRZ865. CME/MOC/CC/AAPA/IPCE credit will be available until April 20, 2027.Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

In this episode, Thomas K Varghese, Jr, MD, FACS, is joined by Carrie Chan, MSN, MPH, from the University of California, San Francisco, and Karthik Balakrishnan, MD, FACS, from Stanford Medicine Children's Health. They discuss their recent article,“Development, Validation, and Comparison of Machine Learning Models for Predicting Pediatric Surgical Site Infections Using the NSQIP-P Database,” which represents the largest study to date on predicting pediatric surgical site infection. The authors developed machine-learning models and ultimately recommend a regularized logistic regression model for clinical integration, balancing performance and feasibility for implementation. Findings support using routine preoperative data for personalized infection prevention and preoperative planning.   Disclosure Information: Ms Chan and Drs Varghese and Balakrishnan have nothing to disclose.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Chan, Carrie T MSN, MPH; Pletcher, Mark J MD, MPH; Balakrishnan, Karthik MD, MPH, FACS; Hswen, Yulin ScD, MPH; Scheffler, Aaron PhD, MS. Development, Validation, and Comparison of Machine Learning Models for Predicting Pediatric Surgical Site Infections Using the NSQIP-P Database. Journal of the American College of Surgeons 242(3):p 712-722, March 2026. | DOI: 10.1097/XCS.0000000000001683   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord

In this episode, Richard Evans, MD, FACS, of Westchester Medical Center Health Network's Western Region and Assistant Professor at New York Medical College, joins the podcast to discuss addressing workforce shortages through innovative education programs. He shares how hands-on training and expanding students' exposure to different career paths are helping build a stronger, more prepared healthcare workforce for the future.

In this episode, Dr. Paula Ferrada, MD, FACS, FCCM, MAMSE, Department of Surgery Chair, Inova Fairfax Hospital, shares how data, trust, and teamwork are transforming perioperative operations, improving access, and boosting efficiency while keeping patients at the center of care.This episode is sponsored by LeanTaaS.

In this segment of Cancer Registry World, Laurie Kirstein, MD, FACS, a breast surgical oncologist in the Division of Surgical Oncology at Memorial Sloan Kettering Cancer Center and current Chair of the American College of Surgeons Commission on Cancer (CoC), discusses her vision and priorities for the CoC. Drawing on the power of cancer registry data, she highlights the essential role Oncology Data Specialists play in advancing cancer care, quality measurement, and program improvement. Tune in to hear how data-driven insights are shaping the future of oncology.

In this podcast, experts Hope S. Rugo, MD, FASCO; Giuseppe Curigliano, MD, PhD; Paolo Tarantino, MD, PhD; and Alastair Thompson, MD, MBChB, BSc (Hons), FRCS (Ed), FACS; discuss and debate recently published results of pivotal clinical trials in early-stage, HER2-positive breast cancer and their implications for patient care.

In this episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026, with guests Baruch D. Kuppermann, MD, PhD and L. Jay Katz, MD. They discuss everything from their unique career journeys to the current treatments and procedures in eye care. Welcome to Eyeluminaries 00:10 Recap of AAO episode 00:34 Intro of Baruch D. Kuppermann, MD, PhD 01:28 What made you enter retina and how has your career evolved? 03:02 The Gavin Herbert Eye Institute 06:02 What are your other interests? 12:09 Nonprofit work and the Armenian EyeCare Project 13:07 Intro of L. Jay Katz, MD 17:14 How did you get into glaucoma? 18:03 How are things going to evolve in treatment and procedures? 20:28 What was the driving force behind leaving academia and working with Glaukos? 25:01 Tell us a favorite Tom Burns story! 26:44 Thank you! 29:50 Baruch D. Kuppermann, MD, PhD, is the Roger F. Steinert Professor, Chair of the Department of Ophthalmology, and Director of the Gavin Herbert Eye Institute at the University of California, Irvine. L. Jay Katz, MD, is the chief medical officer at Glaukos. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X @DrHovanesian.

In this podcast, experts Patrick I. Borgen, MD; Don S. Dizon, MD, FACP, FASCO; Kevin S. Hughes, MD, FACS; and Banu Arun, MD, FASCO; discuss how genetic testing drives breast cancer management from screening and surgical decisions to targeted systemic therapies.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AUX865. CME/MOC/CC/AAPA/IPCE credit will be available until April 5, 2027.Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AUX865. CME/MOC/CC/AAPA/IPCE credit will be available until April 5, 2027.Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AUX865. CME/MOC/CC/AAPA/IPCE credit will be available until April 5, 2027.Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

In this episode, Jeffrey Cohen, MD, FACS, FASCRS, CPE, Executive Vice President and Chief Clinical Operating Officer at Hartford HealthCare, joins the podcast to discuss breakthroughs in outpatient care management and how data is improving safety and quality. He shares insights on HHC 2035 and the shift toward a more consumer-centric healthcare system, along with ways Hartford Healthcare is enhancing the overall patient experience.

Welcome to OncLive On Air®! I'm your host today, Kyle Doherty.OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.In today's episode, we spoke with David Morris, MD, FACS, and Alan H. Bryce, MD. Dr Morris is the president of Urology Associates, PC, in Nashville, Tennessee. Dr Bryce is a medical oncologist and the chief clinical officer of City of Hope Cancer Center Phoenix in Arizona.In our exclusive interview, Drs Morris and Bryce discussed the clinical implications of the FDA's full approval of rucaparib (Rubraca) for BRCA mutation–associated metastatic castration-resistant prostate cancer (mCRPC), including the notable data that supported the regulatory decision and how this agent fits into the mCRPC treatment paradigm.

The latest trends on colorectal cancer surgery and survival with guest Anne Mongiu MD PhD, FACS, FASCRS Yale Cancer Center visit: www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

In this episode, Morgan P. Lorio, MD, FACS, Past President, International Society for the Advancement of Spine Surgery (ISASS), discusses the growing role of AI in spine care and its impact on clinical decision-making, policy, and medical knowledge. He highlights the importance of physician-led governance to ensure technology enhances rather than erodes critical thinking and patient-centered care.

In this episode, Neil Tanna, MD, MBA, FACS, Senior Vice President of System Perioperative Services & Strategy at Northwell Health, joins the podcast to discuss the growing potential of AI in surgical and perioperative care. He shares the importance of strong stakeholder engagement and how access to reliable, actionable data is critical to driving better decision-making and improving outcomes across the system.

In this episode, Neil Tanna, MD, MBA, FACS, Senior Vice President of System Perioperative Services & Strategy at Northwell Health, joins the podcast to discuss the growing potential of AI in surgical and perioperative care. He shares the importance of strong stakeholder engagement and how access to reliable, actionable data is critical to driving better decision-making and improving outcomes across the system.

In this episode, Morgan P. Lorio, MD, FACS, Past President, International Society for the Advancement of Spine Surgery (ISASS), discusses the growing role of AI in spine care and its impact on clinical decision-making, policy, and medical knowledge. He highlights the importance of physician-led governance to ensure technology enhances rather than erodes critical thinking and patient-centered care.

In this episode, Morgan P. Lorio, MD, FACS, Past President, International Society for the Advancement of Spine Surgery (ISASS), discusses the growing role of AI in spine care and its impact on clinical decision-making, policy, and medical knowledge. He highlights the importance of physician-led governance to ensure technology enhances rather than erodes critical thinking and patient-centered care.

Welcome to Teeth & Titanium, Episode 64, “What is a Fellowship?” This episode features: Current Events-    Olympic hockey update-    The old foot on my chest bit-    Getting your FACS right Fan Mail-    LAST Feedback-    Orthognathic Deep dive-    Aura from the Harvard Unc-    The Match Debate-    Does your fellowship count?            Resident reminder            - Questions to ask when looking at a fellowship Journal Club-    The PGY-0: Why the Start of Training Doesn't Have to Wait Till Residency.-    Where Have the Resident Researchers Gone?-    The Value of Orthognathic Surgery Fellowships. Your personal finance drill from PWL Capital-    “Estate Freeze” by Brady Plunkett Senior Wealth Advisor Portfolio Manger, CFP, CIM Recommendations-    Pond rules-    A very long sunrise Be sure to subscribe so you never miss an episode! Apple / Spotify / Google / Online links Thanks to the CAOMS and PWL for their continued support of this podcast. https://www.caoms.com. PWL Capital; https://pwlcapital.com/ If you would like to contact us, be a guest, or would like to submit a topic for Resident Reminder or Journal club, please email us at: teethandtitaniumOMFS@gmail.com Hosted by Dr. Wendall Mascarenhas & Dr. Oscar DalmaoProduced by Dr. Brad W. Ray Articles/Books cited in this episode: Shivers PL, Goncalves PZ. The PGY-0: Why the Start of Training Doesn't Have to Wait Till Residency. J Oral Maxillofac Surg. 2026 Mar;84(3):287-288. Cillo JE Jr. Where Have the Resident Researchers Gone? J Oral Maxillofac Surg. 2026 Mar;84(3):285-286. Ritchie CA, Posnick JC, Kinard BE. The Value of Orthognathic Surgery Fellowships. J Oral Maxillofac Surg. 2026 Mar;84(3):289-290.

Send a textJoin host Christina K. Hardesty, MD, as she speaks with Andrew G. King, MB, ChB, FRACS, FACS, Karen A. Weissmann, MD, PhD—both members of the SRS Historical Committee—and Serena S. Hu, MD, for a special episode in honor of Women's History Month!*The Scoliosis Research Society (SRS) podcast is aimed at delivering the most current and trusted information to clinicians that care for patients with scoliosis and other spinal conditions. From news in the world of spinal conditions, to discussions with thought leaders in the field, we aim to provide up-to-date, quality information that will impact the daily practice of spinal conditions.

In this episode, Vikram Kashyap, MD, FACS, Endowed Chair of the Frederik Meijer Heart and Vascular Institute and Vice President of Cardiovascular Health at Corewell Health, discusses reducing mortality through systemwide collaboration, navigating anesthesia workforce transitions, expanding into heart and lung integration, and building a unified cardiovascular strategy across the state.

Join the Behind the Knife Surgical Oncology Team as we discuss the PRADO and NADINA randomized control trials regarding neoadjuvant therapy in Stage III melanoma with macroscopic nodal disease!Hosts:Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center.Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles.Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 2ndYear Surgical Oncology fellow at MD Anderson.Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a General Surgery physician in the United States Air Force station at RAF Lakenheath.Joe (Joseph) Broderick, MD, MA (@joebrod5) is a General Surgery research resident between his second and third year at Brooke Army Medical Center.Galen Gist, MD (@gistgalen) is a General Surgery research resident between his second and third year at Brooke Army Medical Center. Learning Objectives:-       Evaluate the role of Completion Lymph Node Dissection (CLND) in patients with positive sentinel lymph nodes, specifically citing the lack of melanoma-specific survival benefit vs. the improvement in regional disease control demonstrated in the MSLT-II trial.-       Determine the appropriate surgical excision margins for primary cutaneous melanoma, comparing the outcomes of 1 cm versus 2 cm margins as analyzed in the MINT trial (Lancet 2019).-       Analyze the impact of adjuvant systemic therapy (Anti-PD1/Immunotherapy) on recurrence-free survival in patients with resected high-risk Stage III melanoma.References:Reijers, I.L.M., Menzies, A.M., van Akkooi, A.C.J. et al. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial. Nat Med 28, 1178–1188 (2022). https://doi.org/10.1038/s41591-022-01851-xChristian U. Blank et al. Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.. J Clin Oncol 42, LBA2-LBA2(2024). DOI:10.1200/JCO.2024.42.17_suppl.LBA2*Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US